As of 2025-12-31, the Intrinsic Value of Edgewise Therapeutics Inc (EWTX) is -7.43 USD. This EWTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 26.35 USD, the upside of Edgewise Therapeutics Inc is -128.18%.
Based on its market price of 26.35 USD and our intrinsic valuation, Edgewise Therapeutics Inc (EWTX) is overvalued by 128.18%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.43 - -7.43 | -7.43 | -128.18% |
| P/E | (28.16) - (29.88) | (29.30) | -211.2% |
| DDM - Stable | (16.51) - (67.55) | (42.03) | -259.5% |
| DDM - Multi | (0.23) - (0.71) | (0.35) | -101.3% |
| Market Cap (mil) | 2,789.67 |
| Beta | 2.12 |
| Outstanding shares (mil) | 105.87 |
| Enterprise Value (mil) | 2,743.67 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.14% |
| Cost of Debt | 5.00% |
| WACC | 6.01% |